Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chiesi Takes CF Product To Advisory Cmte. With Modest Efficacy, Many Questions

May 07 2019

• By Michael Cipriano

Cystic fibrosis word cloud

Related Content

Pharmaxis’ CF Drug <em>Bronchitol</em> Gets Thumbs Down From FDA Panel

Jan 31 2013

Pharmaxis Faces New Study Requirement For CF Drug <em>Bronchitol</em>

Apr 16 2013

Pharmaxis’ <em>Bronchitol</em> Will Face Efficacy Questions At FDA Panel Review

Jan 28 2013

<em>Bronchitol</em> AdComm Shows Difficulty Of Following In <em>Kalydeco</em>’s Shadow

Feb 04 2013

Related Companies

Syntara Limited

Cornerstone Pharmaceuticals, Inc.

Additional Topics

United States Advisory Committees Regulation Respiratory BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window